1312 Catumaxomab therapy eliminates putative CD133+ EpCAM+ cancer stem celles from malignant ascites: data from a pivotal phase II/III study

✍ Scribed by H. Lindhofer; A. Schoberth; D. Pelster; J. Hess; J. Herold; M. Jäger

• Book ID: 119600246
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 50 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(09)70485-9